Egbert Smit

PROF.DR.

20032019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP)

Dziadziuszko, R., Smit, E. F., Dafni, U., Wolf, J., Wasąg, B., Biernat, W., Finn, S. P., Kammler, R., Tsourti, Z., Rabaglio, M., Ruepp, B., Roschitzki-Voser, H., Stahel, R. A., Felip, E. & Peters, S., 2019, In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticleAcademicpeer-review

High-throughput RNAi screening reveals cancer-selective lethal targets in the RNA spliceosome

Blijlevens, M., van der Meulen-Muileman, I. H., de Menezes, R. X., Smit, E. F. & van Beusechem, V. W., 31 Jan 2019, In : Oncogene.

Research output: Contribution to journalArticleAcademicpeer-review

Induction of peripheral effector CD8 T-cell proliferation by combination of paclitaxel, carboplatin, and bevacizumab in non–small cell lung cancer patients

de Goeje, P. L., Poncin, M., Bezemer, K., Kaijen-Lambers, M. E. H., Groen, H. J. M., Smit, E. F., Dingemans, A-M. C., Kunert, A., Hendriks, R. W. & Aerts, J. G. J. V., 2019, In : Clinical Cancer Research. 25, 7, p. 2219-2227

Research output: Contribution to journalArticleAcademicpeer-review